Schimke immuno-osseous dysplasia
Last updated 8 Jul 2024
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Schimke immuno-osseous dysplasia is a condition characterised by short stature, kidney disease, and a weakened immune system. People with this condition have flattened spinal bones (vertebrae) that shorten their neck and trunk. The adult height for people with this condition is typically between 3 and 5 feet. Additional skeletal problems in people with Schimke immuno-osseous dysplasia include abnormalities of the hip joints and the end of the leg bones where they meet the hip joint. These skeletal problems can cause the hip joints to break down (degenerate) over time, leading to joint pain and a limited range of movement. This combination of skeletal problems and spinal abnormalities is called spondyloepiphyseal dysplasia as it affects the bones of the spine (spondylo-) and the ends of long bones (epiphyses) in the legs. It affects most people with Schimke immuno-osseous dysplasia.People with Schimke immuno-osseous dysplasia often have kidney (renal) disease that may lead to life-threatening renal failure and end-stage renal disease (ESRD).
Video picks for Genetic conditionsVideo library
Description
Schimke immuno-osseous dysplasia is a condition characterised by short stature, kidney disease, and a weakened immune system. People with this condition have flattened spinal bones (vertebrae) that shorten their neck and trunk. The adult height for people with this condition is typically between 3 and 5 feet. Additional skeletal problems in people with Schimke immuno-osseous dysplasia include abnormalities of the hip joints and the end of the leg bones where they meet the hip joint. These skeletal problems can cause the hip joints to break down (degenerate) over time, leading to joint pain and a limited range of movement. This combination of skeletal problems and spinal abnormalities is called spondyloepiphyseal dysplasia as it affects the bones of the spine (spondylo-) and the ends of long bones (epiphyses) in the legs. It affects most people with Schimke immuno-osseous dysplasia.People with Schimke immuno-osseous dysplasia often have kidney (renal) disease that may lead to life-threatening renal failure and end-stage renal disease (ESRD).
Individuals with Schimke immuno-osseous dysplasia also have a shortage of immune system cells called T cells. T cells identify foreign substances and defend the body against infection. This shortage of T cells causes people with Schimke immuno-osseous dysplasia to have recurrent infections.
Other features frequently seen in people with Schimke immuno-osseous dysplasia include an exaggerated curvature of the lower back (lordosis); darkened patches of skin (hyperpigmentation), typically on the chest and back; abnormalities of the teeth; and a broad nasal bridge with a rounded tip of the nose.
Less common signs and symptoms of Schimke immuno-osseous dysplasia include an accumulation of fatty deposits in the lining of the arteries (atherosclerosis), reduced blood flow to the brain (ischemic stroke), migraine-like headaches, an underactive thyroid gland (hypothyroidism), a decrease in the number of blood cells (anaemia), a lack of sperm (azoospermia), and irregular menstruation.
In severe cases, individuals with Schimke immuno-osseous dysplasia do not survive past childhood. In mild cases, people with Schimke immuno-osseous dysplasia can survive into adulthood.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
Immunoosseous dysplasia, Schimke type
Schimke immunoosseous dysplasia
SIOD
SMARCAL1-related immuno-osseous dysplasia (Schimke type)
Patient picks for Genetic conditions

Allergies, blood and immune system
Immunosuppression
Immune suppression describes a loss of immune function. It can occur for many reasons, including disease, medication, surgery, age or genetics.
by Dr Philippa Vincent, MRCGP

Bones, joints and muscles
Things you might not know about cleidocranial dysplasia
The release of Stranger Things 5 has set us up for a season bursting with nostalgia, excitement, and the heartwarming thrill of friends banding together to face evil. Not only does the show’s finale promise an epic, adventure-packed send-off to 2025, but it also sparks a resurgence of interest in a relatively little-known health condition. Cleidocranial dysplasia (CCD) is a rare inherited condition that affects how teeth and bones develop. Its signs can show up differently in each person, making every case unique. In this article, we take a closer look at CCD and the symptoms that may come with it.
by Victoria Raw

Children's health
Developmental dysplasia of the hip
Developmental dysplasia of the hip is a problem with the way that the hip joint develops. It is usually present from birth although may develop later. It is more common in girls. When developmental dysplasia of the hip is diagnosed and treated early in a young baby, the outcome is usually excellent. If treatment is delayed, the treatment is more complex and has less chance of being successful.
by Dr Jacqueline Payne, FRCGP

Tests and investigations
Faecal immunochemical test
The faecal immunochemical test helps to diagnose bleeding disorders of the gut (intestine).
by Dr Colin Tidy, MRCGP

Medicine
Azathioprine
Azathioprine will be prescribed for you by a specialist doctor. Swallow the tablets whole with plenty of water, after a meal. Do not crush or break the tablets. Azathioprine may reduce your body's resistance to infections. Try to keep away from people who you know are ill. It is important to protect yourself from serious illness by having any vaccinations your doctor offers you.
by Michael Stewart, MRPharmS

Medicine
Mycophenolate mofetil
There are several brands of mycophenolate available and your treatment could be affected by switching between brands. Each time you collect a new supply from your pharmacy, please check to see if your medicine looks the same as before. If it is different, discuss this with your pharmacist who will advise you. Taking mycophenolate could reduce your body's resistance to infections. Try to keep away from people who you know are ill, and report any sign of infection (raised temperature, cough) to your doctor. It is important to protect yourself from serious illness by having any vaccinations your doctor offers you.
by Michael Stewart, MRPharmS
Related patient information and medicines

Patient information leaflet
Hip problems
... an autoimmune disease - your body's immune system attacks itselfYour doctor will check this out. [https://patient.info/health/hip-problems](https://patient.info/health/hip-problems) Causes of hip problems in children Developmental dysplasia of the hip (DDH) A painless condition that can affect newborns, DDH makes the hip joint unstable so that.

Patient information leaflet
Barrett's oesophagus
In Barrett's oesophagus the cells that line the lower gullet (oesophagus) are abnormal. The main cause is long-standing reflux of acid from the stomach into the oesophagus. Barrett's oesophagus Barrett's Oesophagus Barrett's oesophagus is a condition which affects the lower gullet (oesophagus). It i... The changed cells in Barrett's oesophagus can.

Patient information leaflet
Newborn screening test
Immunisations Your baby will usually be offered the first of their childhood immunisations Immunisation... For example, if your baby is found to have a condition where their hip joint is not stable ( developmental dysplasia of the hip Pregnancy ), the joint can be stabilised by putting them in a harness or a plaster cast for a while. Although this.

Patient information leaflet
Premature babies
Premature babies are born too early, before they have fully developed in the womb. They often need extra or intensive medical care and support while their organs continue to develop to a point where they can survive without specialist help. Most premature babies go on to have normal healthy lives, but they are at increased risk of medical and.

Patient information leaflet
Restricted growth
Dwarfism is a medical or genetic condition which causes people to have restricted growth so that they are shorter than average. Specifically, people with dwarfism grow no higher than 4 ft 10 ins (147 cm). ... It tends to be associated with other problems such as a cleft palate, club feet, chest abnormalities and abnormally shaped ears..

Patient information leaflet
Dislocation
Dislocation of artificial hips in the period following hip replacement surgery - this is relatively common as the muscles ... Developmental dysplasia of the hip. This is seen in babies when the hip joint doesn't develop normally. For more information see the separate leaflet called Developmental Dysplasia of the Hip. Partial elbow dislocation in a.
Further reading and references
- Schimke immuno-osseous dysplasia; MedlinePlus, National Library of Medicine.
- Bansal R, Hussain S, Chanana UB, Bisht D, Goel I, Muthuswami R. SMARCAL1, the annealing helicase and the transcriptional co-regulator. IUBMB Life. 2020 Oct;72(10):2080-2096. doi: 10.1002/iub.2354. Epub 2020 Aug 5.
- Beleford DT, Diab M, Qubty WF, Malloy MJ, Long RK, Shieh JT. Schimke immunoosseous dysplasia and management considerations for vascular risks. Am J Med Genet A. 2019 Jul;179(7):1246-1252. doi: 10.1002/ajmg.a.61148. Epub 2019 Apr 30.
- Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, Andre JL, Bogdanovic R, Burguet A, Cockfield S, Cordeiro I, Frund S, Illies F, Joseph M, Kaitila I, Lama G, Loirat C, McLeod DR, Milford DV, Petty EM, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Spranger J, Stein A, Thiele H, Tizard J, Weksberg R, Lupski JR, Stockton DW. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet. 2002 Feb;30(2):215-20. doi: 10.1038/ng821. Epub 2002 Jan 22.
- Clewing JM, Fryssira H, Goodman D, Smithson SF, Sloan EA, Lou S, Huang Y, Choi K, Lucke T, Alpay H, Andre JL, Asakura Y, Biebuyck-Gouge N, Bogdanovic R, Bonneau D, Cancrini C, Cochat P, Cockfield S, Collard L, Cordeiro I, Cormier-Daire V, Cransberg K, Cutka K, Deschenes G, Ehrich JH, Frund S, Georgaki H, Guillen-Navarro E, Hinkelmann B, Kanariou M, Kasap B, Kilic SS, Lama G, Lamfers P, Loirat C, Majore S, Milford D, Morin D, Ozdemir N, Pontz BF, Proesmans W, Psoni S, Reichenbach H, Reif S, Rusu C, Saraiva JM, Sakallioglu O, Schmidt B, Shoemaker L, Sigaudy S, Smith G, Sotsiou F, Stajic N, Stein A, Stray-Pedersen A, Taha D, Taque S, Tizard J, Tsimaratos M, Wong NA, Boerkoel CF. Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat. 2007 Mar;28(3):273-83. doi: 10.1002/humu.20432.
- Deguchi K, Clewing JM, Elizondo LI, Hirano R, Huang C, Choi K, Sloan EA, Lucke T, Marwedel KM, Powell RD Jr, Santa Cruz K, Willaime-Morawek S, Inoue K, Lou S, Northrop JL, Kanemura Y, van der Kooy D, Okano H, Armstrong DL, Boerkoel CF. Neurologic phenotype of Schimke immuno-osseous dysplasia and neurodevelopmental expression of SMARCAL1. J Neuropathol Exp Neurol. 2008 Jun;67(6):565-77. doi: 10.1097/NEN.0b013e3181772777.
- Elizondo LI, Cho KS, Zhang W, Yan J, Huang C, Huang Y, Choi K, Sloan EA, Deguchi K, Lou S, Baradaran-Heravi A, Takashima H, Lucke T, Quiocho FA, Boerkoel CF. Schimke immuno-osseous dysplasia: SMARCAL1 loss-of-function and phenotypic correlation. J Med Genet. 2009 Jan;46(1):49-59. doi: 10.1136/jmg.2008.060095. Epub 2008 Sep 19.
- Lippner E, Lucke T, Salgado C, Boerkoel C, Lewis DB. Schimke Immunoosseous Dysplasia. 2002 Oct 1 [updated 2023 Mar 30]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1376/
- Lou S, Lamfers P, McGuire N, Boerkoel CF. Longevity in Schimke immuno-osseous dysplasia. J Med Genet. 2002 Dec;39(12):922-5. doi: 10.1136/jmg.39.12.922. No abstract available.
- Lucke T, Clewing JM, Boerkoel CF, Hartmann H, Das AM, Knauth M, Becker H, Donnerstag F. Cerebellar atrophy in Schimke-immuno-osseous dysplasia. Am J Med Genet A. 2007 Sep 1;143A(17):2040-5. doi: 10.1002/ajmg.a.31878.
- Merli P, Guzzo I, Locatelli F. Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia. N Engl J Med. 2022 Sep 1;387(9):859. doi: 10.1056/NEJMc2209527. No abstract available.
- Zieg J, Bezdicka M, Nemcikova M, Balascakova M, Sukova M, Sterbova K, Vondrak K, Dusek J, Krepelova A. Schimke immunoosseous dysplasia: an ultra-rare disease. a 20-year case series from the tertiary hospital in the Czech Republic. Ital J Pediatr. 2023 Jan 19;49(1):11. doi: 10.1186/s13052-023-01413-y.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

